Literature DB >> 18762225

Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.

Lindomar Pena1, Mauro Pires Moraes, Marla Koster, Thomas Burrage, Juan M Pacheco, Fayna Diaz-San Segundo, Marvin J Grubman.   

Abstract

To develop a more efficacious human adenovirus (Ad5)-vectored foot-and-mouth disease virus (FMDV) subunit vaccine (Ad5-A24) we have included coding regions for FMDV nonstructural proteins 2B and 2C. These proteins are involved in membrane re-arrangements resulting in the proliferation of cytoplasmic vesicles which serve as the sites of virus replication. Cells infected with a vector containing full-length 2B (Ad5-CI-A24-2B) had a significant increase in the number of cytoplasmic vesicles as compared to cells infected with the original vector or a vector containing full-length 2BC. Swine inoculated with Ad5-CI-A24-2B developed an enhanced FMDV-specific neutralizing antibody response as compared to animals inoculated with the original vector and showed no clinical signs of disease after challenge. In a second experiment animals vaccinated with Ad5-CI-A24-2B were not fully protected but had a more rapid and robust humoral response and two out of three pigs had delayed and less severe disease than animals in the other vaccinated groups. These results suggest that incorporation of the complete coding region of 2B into the vaccine enhances its potency and protective efficacy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762225     DOI: 10.1016/j.vaccine.2008.08.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

2.  Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Authors:  Fayna Díaz-San Segundo; Marcelo Weiss; Eva Pérez-Martín; Camila C Dias; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

3.  Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.

Authors:  Jared R Patch; Lasse E Pedersen; Felix N Toka; Mauro Moraes; Marvin J Grubman; Morten Nielsen; Gregers Jungersen; Soren Buus; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

4.  Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination.

Authors:  Jared R Patch; Mary Kenney; Juan M Pacheco; Marvin J Grubman; William T Golde
Journal:  Viral Immunol       Date:  2013-07-05       Impact factor: 2.257

5.  Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus.

Authors:  Steven M Szczepanek; Roger W Barrette; Debra Rood; Diana Alejo; Lawrence K Silbart
Journal:  Clin Vaccine Immunol       Date:  2012-02-08

6.  Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.

Authors:  Fayna Diaz-San Segundo; Mauro P Moraes; Teresa de Los Santos; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

7.  Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.

Authors:  Gisselle N Medina; Nestor Montiel; Fayna Diaz-San Segundo; Diego Sturza; Elizabeth Ramirez-Medina; Marvin J Grubman; Teresa de los Santos
Journal:  Clin Vaccine Immunol       Date:  2015-11-25

8.  Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids.

Authors:  Ana Clara Mignaqui; Vanesa Ruiz; Sylvie Perret; Gilles St-Laurent; Parminder Singh Chahal; Julia Transfiguracion; Ayelén Sammarruco; Victoria Gnazzo; Yves Durocher; Andrés Wigdorovitz
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

9.  Construction and characterization of recombinant human adenovirus type 5 expressing foot-and-mouth disease virus capsid proteins of Indian vaccine strain, O/IND/R2/75.

Authors:  Ramesh Kumar; B P Sreenivasa; R P Tamilselvan
Journal:  Vet World       Date:  2015-02-10

Review 10.  Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs.

Authors:  Nicholas A Lyons; Young S Lyoo; Donald P King; David J Paton
Journal:  Front Vet Sci       Date:  2016-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.